Ma S, Pu N, Ma J
Ren Fail. 2023; 45(1):2147436.
PMID: 37427760
PMC: 10334859.
DOI: 10.1080/0886022X.2022.2147436.
Lengton R, van der Willik E, de Rooij E, Meuleman Y, le Cessie S, Michels W
Nephrol Dial Transplant. 2022; 38(6):1508-1518.
PMID: 36549655
PMC: 10229298.
DOI: 10.1093/ndt/gfac341.
Canaud B, Stuard S, Laukhuf F, Yan G, Canabal M, Lim P
Clin Kidney J. 2022; 14(Suppl 4):i45-i58.
PMID: 34987785
PMC: 8711767.
DOI: 10.1093/ckj/sfab198.
Bowry S, Kircelli F, Misra M
Clin Kidney J. 2022; 14(Suppl 4):i32-i44.
PMID: 34987784
PMC: 8711754.
DOI: 10.1093/ckj/sfab182.
Zhang Z, Li M, Yu H, Zhao J, Xiao F, Xuan F
Ther Clin Risk Manag. 2021; 17:127-133.
PMID: 33542633
PMC: 7853439.
DOI: 10.2147/TCRM.S288023.
Efficacy of different hemodialysis methods on dendritic cell marker CD40 and CD80 and platelet activation marker CD62P and P10 in patients with chronic renal failure.
Wang X, Zhang B, Lu X, Wang P
J Clin Lab Anal. 2018; 33(3):e22713.
PMID: 30499177
PMC: 6818601.
DOI: 10.1002/jcla.22713.
Levels of cystatin C in low- and high-flux hemodialysis in children with end-stage renal disease.
Fadel F, Mourad A, Abdel Rahman A, Bazaraa H, Mohamed M, El-Lebedy D
Pediatr Nephrol. 2017; 32(9):1603-1609.
PMID: 28417217
DOI: 10.1007/s00467-017-3661-0.
The effect of albumin leakage in hemodialysis patients on redox status of serum albumin.
Nagai K, Tsuchida K, Hirose D, Michiwaki H, Hann M, Kanayama H
J Artif Organs. 2016; 19(3):310-4.
PMID: 27086124
DOI: 10.1007/s10047-016-0900-2.
Dialyzer Reuse and Outcomes of High Flux Dialysis.
Argyropoulos C, Roumelioti M, Sattar A, Kellum J, Weissfeld L, Unruh M
PLoS One. 2015; 10(6):e0129575.
PMID: 26057383
PMC: 4461247.
DOI: 10.1371/journal.pone.0129575.
Analysis of time to event outcomes in randomized controlled trials by generalized additive models.
Argyropoulos C, Unruh M
PLoS One. 2015; 10(4):e0123784.
PMID: 25906075
PMC: 4408032.
DOI: 10.1371/journal.pone.0123784.
High-flux and low-flux membranes: efficacy in hemodialysis.
Oshvandi K, Kavyannejad R, Borzuo S, Gholyaf M
Nurs Midwifery Stud. 2015; 3(3):e21764.
PMID: 25699283
PMC: 4332995.
DOI: 10.17795/nmsjournal21764.
Comparison of the impact of high-flux dialysis on mortality in hemodialysis patients with and without residual renal function.
Kim H, Kim S, Kim Y, Jin D, Song H, Choi E
PLoS One. 2014; 9(6):e97184.
PMID: 24906205
PMC: 4048156.
DOI: 10.1371/journal.pone.0097184.
Resistance to erythropoiesis stimulating agents in patients treated with online hemodiafiltration and ultrapure low-flux hemodialysis: results from a randomized controlled trial (CONTRAST).
van der Weerd N, den Hoedt C, Blankestijn P, Bots M, van den Dorpel M, Levesque R
PLoS One. 2014; 9(4):e94434.
PMID: 24743493
PMC: 3990567.
DOI: 10.1371/journal.pone.0094434.
High-flux versus low-flux membranes for end-stage kidney disease.
Palmer S, Rabindranath K, Craig J, Roderick P, Locatelli F, Strippoli G
Cochrane Database Syst Rev. 2012; (9):CD005016.
PMID: 22972082
PMC: 6956628.
DOI: 10.1002/14651858.CD005016.pub2.
Home haemodialysis and uraemic toxin removal: does a happy marriage exist?.
Vanholder R, Eloot S, Neirynck N, Van Biesen W
Nat Rev Nephrol. 2012; 8(10):579-88.
PMID: 22926247
DOI: 10.1038/nrneph.2012.189.
Hemodiafiltration and survival of end-stage renal disease patients: the long journey goes on.
Schmid H, Schiffl H
Int Urol Nephrol. 2012; 44(5):1435-40.
PMID: 22752499
DOI: 10.1007/s11255-012-0232-y.
Optimal hemodialysis prescription: do children need more than a urea dialysis dose?.
Michel F, Ariane Z, Betti S, Peter S
Int J Nephrol. 2011; 2011:951391.
PMID: 21660260
PMC: 3108240.
DOI: 10.4061/2011/951391.
Hemodiafiltration: the addition of convective flow to hemodialysis.
Fischbach M, Fothergill H, Zaloszyc A, Seuge L
Pediatr Nephrol. 2011; 27(3):351-6.
PMID: 21298503
DOI: 10.1007/s00467-011-1779-z.
